Ceremorphic appoints Suresh Katta and Camillo Martino to its Board of Directors

– USA, CA –  Ceremorphic, a fabless silicon and system development company, today announced the appointments of Suresh Katta and Camillo Martino to its Board of Directors.

About Suresh Katta

As the founder of Saama Technologies in 2007, Suresh has successfully leveraged AI to reshape businesses across different verticals, including a significant contribution to life sciences. In June 2022, Suresh was elevated to Chairman Emeritus of Saama’s Board, following his leadership in stewarding Saama’s partnership with Pfizer to develop the world’s first COVID-19 vaccine in less than one year. In 2021, he architected a bold new strategic growth investment for Saama with global investment firm Carlyle and a unique consortium of the corporate venture arms of major pharmaceutical companies, including Pfizer, Merck, Amgen, and McKesson.

As one of the world’s most inspiring data & analytics innovators, Suresh serves on the Board of Directors of OneCell Diagnostics, a genomics-based Precision Oncology company providing comprehensive genomic solutions for better cancer management, as well as The Stimson Center, which promotes international security and shared prosperity through applied research and independent analysis, global engagement, and policy innovation. Previously, Suresh served on the Board of Directors of the Association of Clinical Research Organizations, advocating for safe, ethical clinical trials that protect patients and ensure high-quality results. In recognition of his contributions, Suresh was named PM360’s 2018 ELITE Entrepreneur and one of PharmaVOICE’s 100 Most Inspirational Leaders. He frequently contributes to industry publications and is a sought-after featured speaker for industry conferences and panels. Before founding Saama, Suresh successfully launched two startups.

Suresh holds Honorary Doctorate degrees from Ajeenkya DY Patil University and MIT ADT University in Pune, India. He received a Master of Science in Computer Engineering from the University of Louisiana at Lafayette and a Bachelor of Science in Electrical and Electronics Engineering from RV College of Engineering.

About Camillo Martino

Camillo Martino is a semiconductor veteran and currently serves as a board member and executive advisor to multiple technology companies. Camillo is currently the Chair of the Board of Directors of Magnachip and has served as a member of its Board since 2016. He has also been a Board Member of CXApp since 2020 and Sensera since 2018. Camillo also serves on the Board of Directors at multiple privately held companies, including VVDN Technologies and Sakuu.

Previously, Camillo served as a member of the Board of Directors at Cypress Semiconductor from June 2017 through to the sale of the company to Infineon in April 2020. He also served as a Director of Moschip Technologies (BOM: 532407) from 2017 to 2019, and as a director and CEO of Silicon Image, Inc., a global semiconductor company, from January 2010 until the completion of its sale to Lattice Semiconductor Corporation in March 2015. From 2008 to 2009, Camillo served as COO of SAI Technology Inc. and also as a director from 2007 to 2010. From 2005 to 2007, he served as the CEO and director of Cornice Inc., and from 2001 to 2005, he served as EVP and COO at Zoran Corporation, a global semiconductor company. Before that, Camillo held multiple positions with National Semiconductor Corporation for a total of nearly 14 years in four countries.

Camillo holds a Bachelor of Applied Science from the University of Melbourne and a Graduate Diploma (in Digital Communications) from Monash University in Australia.

About Ceremorphic

Founded in April 2020, Ceremorphic currently has 160 full-time employees dedicated to solving the compute performance and energy efficiency requirements of AI supercomputing and Generative AI. Leveraging over 200 patents and proven expertise in creating industry-leading silicon and system products, Ceremorphic has developed a ground-up architecture with century defining innovations that will transform the computing and life sciences fields. The company develops advanced system products based on its silicon in TSMC 5nm and 3nm process nodes.

For more information: https://ceremorphic.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.